No Significant Concern in the ER for This Patient
A heart rate of 60 bpm in a patient on metoprolol for SVT history is an expected therapeutic effect, not a pathologic bradycardia requiring emergency intervention. This patient is asymptomatic (no chest pain, shortness of breath, or hemodynamic instability), making this a reassuring clinical picture.
Understanding the Clinical Context
Metoprolol's Expected Effects
Metoprolol is a beta-blocker specifically used for rate control and prevention of SVT recurrence. The FDA label explicitly warns that bradycardia is a known effect of metoprolol therapy 1. A heart rate of 60 bpm falls within normal sinus rhythm range (60-100 bpm) and represents appropriate beta-blockade, not pathologic bradycardia.
When Beta-Blocker Bradycardia Becomes Concerning
The FDA guidance indicates concern when there is 1:
- Severe bradycardia (typically <50 bpm with symptoms)
- Sinus pause, heart block, or cardiac arrest
- Hemodynamic instability (hypotension, altered mental status, syncope)
- Symptomatic bradycardia (dizziness, syncope, chest pain, dyspnea)
Your patient has none of these red flags.
What "Supraventricular Bradycardia" Actually Means
The term "supraventricular bradycardia" in this context likely refers to sinus bradycardia (HR <60 bpm originating from the SA node). This is distinct from SVT, which by definition requires heart rates >100 bpm 2, 3.
Causes of Sinus Bradycardia in This Patient:
- Therapeutic beta-blockade (most likely) - metoprolol intentionally slows AV nodal conduction 3, 4
- Athletic conditioning (if applicable)
- Vagal tone (rest, sleep)
- Hypothyroidism (though metoprolol can mask signs 1)
- Intrinsic sinus node dysfunction (less likely given asymptomatic presentation)
Risk Stratification for This Patient
Low-Risk Features (Present):
- HR 60 bpm (not severely bradycardic)
- Asymptomatic
- Known beta-blocker therapy
- Established cardiology follow-up
- No acute coronary syndrome symptoms
High-Risk Features (Absent):
- Severe bradycardia (<50 bpm)
- Hemodynamic compromise
- Syncope or presyncope
- New heart block on EKG
- Acute decompensated heart failure
Appropriate ER Management
No intervention is required for this asymptomatic patient with HR 60 on chronic beta-blocker therapy. However, perform these assessments:
Essential EKG Review:
- Confirm sinus rhythm (P waves before each QRS)
- Rule out heart block (check PR interval <200 ms, consistent 1:1 AV conduction)
- Exclude sinus pauses (no pauses >3 seconds)
- Assess QRS duration (narrow complex reassuring)
Clinical Pitfalls to Avoid:
- Do not discontinue metoprolol abruptly - FDA warns this can precipitate severe angina, MI, or ventricular arrhythmias in patients with coronary disease 1
- Do not treat asymptomatic bradycardia - HR 60 is not pathologic
- Do not assume medication non-compliance - the patient may actually be taking medications appropriately
When to Escalate Care:
Contact the patient's cardiologist if:
- HR drops below 50 bpm
- Development of symptoms (dizziness, syncope, dyspnea)
- New heart block on EKG (second-degree type II or third-degree)
- Hemodynamic instability develops
Disposition
Discharge home with cardiology follow-up as already scheduled. The patient's existing cardiologist can assess whether metoprolol dose adjustment is needed, though current HR suggests appropriate therapeutic effect for SVT prevention 3.
Document that the patient is on appropriate beta-blocker therapy for SVT history, is asymptomatic, and has normal sinus rhythm at 60 bpm without concerning EKG findings.